2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
Xueyin Zu(China-US (Henan) Hormel Cancer Institute), Dong Joon Kim(Hallym University)
Cited by 21
Related Papers
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer
|Cellular and Molecular Life Sciences|2023|18